Expression and methylation status of the Syk gene in cervical carcinoma

Archives of Gynecology and Obstetrics

Volumn 283, Issue 5, 2011, Pages 1113-1119

  Zhao, Shuping ^a,b   Sun, Guixia ^a   Tony, Parks W ^b   Ma, Dehua ^a   Zhao, Chengquan ^b  

^a QINGDAO UNIVERSITY   (China)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cervical cancer; Cervical neoplasm; DNA methylation; Gene; Gene methylation; mRNA expression; Spleen tyrosine kinase; Suppressor

Indexed keywords

GENOMIC DNA; MESSENGER RNA; PROTEIN KINASE SYK;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN TYROSINE KINASE GENE; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; AGED; CARCINOMA; CELL LINE, TUMOR; CERVIX UTERI; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROTEIN-TYROSINE KINASES; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 79956156559     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-010-1546-6     Document Type: Article

References (46)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156 (Pubitemid 32911406)
2. zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342-350
3. Magnusson PK, Gyllensten UB (2000) Cervical cancer risk: is there a genetic component? Mol Med Today 6:145-148
4. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Cancer 3:415-428 (Pubitemid 34587077)
5. Baylin SB, Herman JG (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16:168-174 (Pubitemid 30169152)
6. Jones PA, Laird PW (1999) Cancer epigenetics comes of age. Nat Genet 21:163-167 (Pubitemid 29070360)
7. Katargin AN, Pavlova LS, Kisseljov FL, Kisseljova NP (2009) Hypermethylation of genomic 3.3-kb repeats is frequent event in HPV-positive cervical cancer. BMC Med Genomics 2:30
8. Ki KD, Lee SK, Tong SY, Lee JM, Song DH, Chi SG (2008) Role of 5′-CpG island hypermethylation of the FHIT gene in cervical carcinoma. J Gynecol Oncol 19(2):117-122
9. Ongenaert M, Wisman GB, Volders HH, Koning AJ, Zee AG, van Criekinge W, Schuuring E (2008) Discovery of DNA methylation markers in cervical cancer using relaxation ranking. BMC Med Genomics 1:57
10. Zhao XL, Meng ZY, Qiao YH, Zhang HL (2008) Promoter methylation of DAPK gene in cervical carcinoma. Ai Zheng 27(9):919-923 (Chinese Journal)
11. Gokul G, Gautami B, Malathi S, Sowjanya AP, Poli UR, Jain M, Ramakrishna G, Khosla S (2007) DNA methylation profile at the DNMT3L promoter: a potential biomarker for cervical cancer. Epigenetics 2(2):80-85 (Pubitemid 351682000)
12. Shivapurkar N, Sherman ME, Stastny V, Echebiri C, Rader JS, Nayar R, Bonfiglio TA, Gazdar AF, Wang SS (2007) Evaluation of candidate methylation markers to detect cervical neoplasia. Gynecol Oncol 107(3):549-553 (Pubitemid 350160871)
13. Oikonomou P, Messinis I, Tsezou A (2007) DNA methylation is not likely to be responsible for hTERT expression in premalignant cervical lesions. Exp Biol Med (Maywood) 232(7):881-886 (Pubitemid 47026793)
14. Feng Q, Hawes SE, Stern JE, Dem A, Sow PS, Dembele B, Toure P, Sova P, Laird PW, Kiviat NB (2007) Promoter hypermethylation of tumor suppressor genes in urine from patients with cervical neoplasia. Cancer Epidemiol Biomarkers Prev 16(6):1178-1184 (Pubitemid 46984956)
15. Kitkumthorn N, Yanatatsanajit P, Kiatpongsan S, Phokaew C, Triratanachat S, Trivijitsilp P, Termrungruanglert W, Tresukosol D, Niruthisard S, Mutirangura A (2006) Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer. BMC Cancer 6:55
16. Coopman PJ, Do MT, Barth M et al (2000) The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 406(8):742-747
17. Ulanova M, Puttagunta L, Marcet-Palacios M, Duszyk M, Steinhoff U, Duta F, Kim MK, Indik ZK, Schreiber AD, Befus AD (2005) Syk tyrosine kinase participates in betal-integrin signaling and inflammatory responses in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 288(3):497-507
18. Yamada T, Fujieda S, Yanagi S, Yamamura H, Inatome R, Sunaga H, Saito H (2001) Protein-tyrosine kinase Syk expressed in human nasal fibroblasts and its effect on RANTES production. J Immunol 166(1):538-543 (Pubitemid 32038474)
19. Inatome R, Yanagi S, Takano T, Yamamura H (2001) A critical role for Syk in endothelial cell proliferation and migration. Biochem Biophys Res Commun 286(1):195-199 (Pubitemid 32917669)
20. Tsujimura T, Yanagi S, Inatome R, Takano T, Ishihara I, Mitsui N, Takahashi S, Yamamura H (2001) Syk protein-tyrosine kinase is involved in neuron-like differentiation of embryonal carcinoma P19 cells. FEBS Lett 489(2-3):129-133 (Pubitemid 32126395)
21. Yuan Y, Wang J, Li J, Wang L, Li M, Yang Z, Zhang C, Dai JL (2006) Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma. Clin Cancer Res 12(22):6687-6695 (Pubitemid 44876836)
22. Hoeller C, Thallinger C, Pratscher B, Bister MD, Schicher N, Loewe R, Heere-Ress E, Roka F, Sexl V, Pehamberger H (2005) The non-receptor-associated tyrosine kinase Syk is a regulator of metastatic behavior in human melanoma cells. J Invest Dermatol 124(6):1293-1299 (Pubitemid 40847418)
23. Turner M, Schweighoffer E, Colucci F, Di Santo JP, Tybulewicz VL (2000) Tyrosine kinase SYK: essential functions for immunoreceptor signaling. Immunol Today 21(3):148-154 (Pubitemid 30122705)
24. Kurosaki T (1997) Molecular mechanisms in B cell antigen receptor signaling. Curr Opin Immunol 9:309-318
25. Chu DH, Morita CT, Weiss A (1998) The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol Rev 165:167-180 (Pubitemid 28524211)
26. Kiefer F, Brumell J, Al-Alawi N, Latour S, Cheng A, Veillette A, Grinstein S, Pawson T (1998) The Syk protein tyrosine kinase is essential for Fcc receptor signaling in macrophages and neutrophils. Mol Cell Biol 18:4209-4220 (Pubitemid 28287944)
27. Rumbaugh KM, Binstadt BA, Billadeau DD, Schoon RA, Dick CJ, Ten RM, Leibson PJ (1997) Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity. J Exp Med 186:1965-1974 (Pubitemid 28013680)
28. Yanagi S, Inatome R, Takano T, Yamamura H (2001) Syk expression and novel function in a wide variety of tissues. Biochem Biophys Res Commun 288:495-498 (Pubitemid 33030056)
29. Sada K, Takano T, Yanagi S, Yamamura H (2001) Structure and function of Syk protein-tyrosine kinase. J Biochem 130:177-186 (Pubitemid 32785863)
30. Yuan Y, Mendez R, Sahin A, Dai JL (2001) Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res 61:5558-5561 (Pubitemid 32694942)
31. Toyama T, Iwase H, Yamashita H, Hara Y, Omoto Y, Sugiura H, Zhang Z, Fujii Y (2003) Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer. Cancer Lett 189(1):97-102 (Pubitemid 35351524)
32. Ding YB, Wu ZY, Wang S, Zha XM, Zheng W, Liu XA, Fan P (2004) Hypermethylation of Syk gene in promoter region is associated with oncogenesis, metastasis of breast carcinoma. Natl Med J China 84:290-293
33. Zhang X, Shrikhande U, Alicie BM, Zhou Q, Geahlen RL (2009) A role for the protein-tyrosine kinase, Syk, in regulating cell-cell adhesion and motility in breast cancer cells. Mol Cancer Res 7(5):634-644
34. Lu J, Lin WH, Chen SY, Longnecker R, Tsai SC, Chen CL, Tsai CH (2006) Syk tyrosine kinases mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J Biol Chem 281:8806-8814 (Pubitemid 43847987)
35. Luangdilok S, Box C, Patterson L, Court W, Harrington K, Pitkin L, Rhŷs-Evans P, O-charoenrat P, Eccles S (2007) Syk tyrosine kinases is linked to cell motility and progression in squamous cell carcinomas of the head and neck. Cancer Res 67:7907-7916 (Pubitemid 47281387)
36. Nakashima H, Natsugoe S, Ishigami S, Okumura H, Matsumoto M, Hokita S, Aikou T (2006) Clinical significance of nuclear expression of spleen tyrosine kinase (Syk) in gastric cancer. Cancer Lett 236(1):89-94
37. Li J, Sidell N (2005) Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase. Int J Cancer 117:14-20 (Pubitemid 41262755)
38. Yang ZL, Wang JP, Yuan YF, Huang MJ (2005) Hypermethylation of SYK gene in promoter region and its association with invasion in colorectal cancer. Zhong Hua Shi Yan Wai Ke Za Zhi 22(1):68-70
39. Stewart ZA, Pietenpol JA (2001) Syk: a new player in the field of breast cancer. Breast Cancer Res 3(1):5-7 (Pubitemid 32223644)
40. Calvisi DF, Ladu S, Gorden A, Farina M, Lee JS, Conner EA, Schroeder I, Factor VM, Thorgeirsson SS (2007) Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest 117:2713-2722 (Pubitemid 47494371)
41. Ehrlich M (2002) DNA methylation in cancer: too much, but also too little. Oncogene 21:5400-5413
42. Suzuki K, Suzuki I, Leodolter A, Alonso S, Horiuchi S, Yamashita K, Perucho M (2006) Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 9:199-207 (Pubitemid 43357946)
43. Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ, Kang GH (2003) Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol 163(4):1371-1378 (Pubitemid 37175085)
44. Sung YM, Xu X, Sun J, Mueller D, Sentissi K, Johnson P, Urbach E, Seillier-Moiseiwitsch F, Johnson MD, Mueller SC (2009) Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo. PLoS One 4(10):e7445
45. Zhou F, Hu J, Ma H, Harrison ML, Geahlen RL (2006) Nucleocytoplasmic trafficking of the Syk protein tyrosine kinase. Mol Cell Biol 26(9):3478-3491
46. Bailet O, Fenouille N, Abbe P, Robert G, Rocchi S, Gonthier N, Denoyelle C, Ticchioni M, Ortonne JP, Ballotti R, Deckert M, Tartare-Deckert S (2009) Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest. Cancer Res 69(7):2748-2756